Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD45RA-depleted DLI for Refractory Viral Infections After Stem Cell Transplant
NCT07662369Phase 2Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of CD45RA depleted donor lymphocyte infusion in viral infection, sponsored by Ruijin Hospital. Started Jun 2026; status: recruiting.
02
Drugs
CD45RA depleted donor lymphocyte infusion
03
Conditions
viral infection
Beyond the preview
Go deeper on NCT07662369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07662369.